Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?

Peptides

Volumn 24, Issue 11, 2003, Pages 1693-1703

  Papo, Niv ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Antimicrobial peptides; Glycocalix layer; LPS; Model phospholipids membranes; Peptide lipid interactions; Peptidoglycan

Indexed keywords

AMPHOLYTE; ANTIINFECTIVE AGENT; DERMASEPTIN; LIPOPOLYSACCHARIDE; MAGAININ 2; MATRIX PROTEIN; OLIGOMER; PARDAXIN; PEPTIDE DERIVATIVE; PEPTIDOGLYCAN; PHOSPHOLIPID;

ANTIMICROBIAL ACTIVITY; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; BACTERIUM; CELL MEMBRANE; CYTOPLASM; DEPOLARIZATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ERYTHROCYTE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LIPID VESICLE; MAMMAL CELL; MEMBRANE BINDING; MICROBIAL SENSITIVITY TEST; NONHUMAN; OUTER MEMBRANE; PHOSPHOLIPID MEMBRANE; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; REVIEW; SALMONELLA TYPHIMURIUM; STREPTOCOCCUS PYOGENES;

MAMMALIA; PROKARYOTA;

EID: 1042267410     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.09.013     Document Type: Article

References (100)

1. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immun. 13:1995;61-92.
2. Nicolas P., Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49:1995;277-304.
3. Hancock R.E., Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:2000;402-410.
4. Brotz H., Sahl H.G. New insights into the mechanism of action of antibiotics-diverse biological effects by binding to the same molecular target. J. Antimicrob. Chemother. 46:2000;1-6.
5. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415:2002;389-395.
6. Breukink E., de Kruijff B. The lantibiotic nisin, a special case or not? Biochim. Biophys. Acta. 1462:1999;223-234.
7. Dimarcq J.L., Bulet P., Hetru C., Hoffmann J. Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers. 47:1998;465-477.
8. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. 1462:1999;55-70.
9. Tossi A., Sandri L., Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers. 55:2000;4-30.
10. Shai Y., Oren Z. Diastereoisomers of cytolysins, a novel class of potent antibacterial peptides. J. Biol. Chem. 271:1996;7305-7308.
11. Oren Z., Hong J., Shai Y. A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J. Biol. Chem. 272:1997;14643-14649.
12. Shai Y., Oren Z. From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides. 22:2001;1629-1641.
13. Papo N., Oren Z., Pag U., Sahl H.G., Shai Y. The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. J. Biol. Chem. 277:2002;33913-33921.
14. Liu D., DeGrado W.F. De novo design, synthesis, and characterization of antimicrobial beta-peptides. J. Am. Chem. Soc. 123:2001;7553-7559.
15. Porter E.A., Wang X., Lee H.S., Weisblum B., Gellman S.H. Non-haemolytic beta-amino-acid oligomers. Nature. 404:2000;565.
16. Porter E.A., Weisblum B., Gellman S.H. Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides. J. Am. Chem. Soc. 124:2002;7324-7330.
17. Raguse T.L., Porter E.A., Weisblum B., Gellman S.H. Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency. J. Am. Chem. Soc. 124:2002;12774-12785.
18. Epand R.F., Umezawa N., Porter E.A., Gellman S.H., Epand R.M. Interactions of the antimicrobial beta-peptide beta-17 with phospholipid vesicles differ from membrane interactions of magainins. Eur. J. Biochem. 270:2003;1240-1248.
19. Tew G.N., Liu D., Chen B., Doerksen R.J., Kaplan J., Carroll P.J.et al. De novo design of biomimetic antimicrobial polymers. Proc. Natl. Acad. Sci. U.S.A. 99:2002;5110-5114.
20. Papo N., Shai Y. Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides. Biochemistry. 42:2003;458-466.
21. Steiner H., Hultmark D., Engstrom A., Bennich H., Boman H.G. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature. 292:1981;246-248.
22. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA. 84:1987;5449-5453.
23. Mor A., Nguyen V.H., Delfour A., Migliore-Samour D., Nicolas P. Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin. Biochemistry. 30:1991;8824-8830.
24. Habermann E., Jentsch J., Hoppe Seyler's Z. Physiol. Chem. 348:1967;37-50.
25. Shai Y., Fox J., Caratsch C., Shih Y.L., Edwards C., Lazarovici P. Sequencing and synthesis of pardaxin, a polypeptide from the Red Sea Moses sole with ionophore activity. FEBS Lett. 242:1988;161-166.
26. Prenner E.J., Lewis R.N., Neuman K.C., Gruner S.M., Kondejewski L.H., Hodges R.S.et al. Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers. A possible relationship to membrane-disrupting activity. Biochemistry. 36:1997;7906-7916.
27. Mignogna G., Simmaco M., Kreil G., Barra D. Antibacterial and haemolytic peptides containing D-alloisoleucine from the skin of Bombina variegata. EMBO J. 12:1993;4829-4832.
28. Barra D., Simmaco M. Amphibian skin: a promising resource for antimicrobial peptides. Trends Biotechnol. 13:1995;205-209.
29. Frohm M., Agerberth B., Ahangari G., Stahle-Backdahl M., Liden S., Wigzell H.et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272:1997;15258-15263.
30. Johansson J., Gudmundsson G.H., Rottenberg M.E., Berndt K.D., Agerberth B. Conformation-dependent antibacterial activity of the naturally-occuring human peptide LL-37. J. Biol. Chem. 273:1998;3718-3724.
31. Andreu D., Rivas L. Animal antimicrobial peptides: an overview. Biopolymers. 47:1998;415-433.
32. Hancock R.E., Scott M.G. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. USA. 97:2000;8856-8861.
33. Hoffmann J.A., Reichhart J.M. Drosophila innate immunity: an evolutionary perspective. Nat. Immunol. 3:2002;121-126.
34. Park C.B., Kim M.S., Kim S.C. A novel antimicrobial peptide from Bufo bufo gargarizans. Biochem. Biophys. Res. Commun. 218:1996;408-413.
35. Raj P.A., Soni S.D., Levine M.J. Membrane-induced helical conformation of an active candidacidal fragment of salivary histatins. J. Biol. Chem. 269:1994;9610-9619.
36. Selsted M.E., Novotny M.J., Morris W.L., Tang Y.Q., Smith W., Cullor J.S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 267:1992;4292-4295.
37. Storici P., Zanetti M. A novel cDNA sequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence. Biochem. Biophys. Res. Commun. 196:1993;1363-1368.
38. Harwig S.S., Swiderek K.M., Lee T.D., Lehrer R.I. Determination of disulphide bridges in PG-2, an antimicrobial peptide from porcine leukocytes. J. Pept. Sci. 1:1995;207-215.
39. Vizioli J., Salzet M. Antimicrobial peptides versus parasitic infections? Trends Parasitol. 18:2002;475-476.
40. Bulet P., Hetru C., Dimarcq J.L., Hoffmann D. Antimicrobial peptides in insects structure and function. Dev. Comp. Immunol. 23:1999;329-344.
41. Hoffmann J.A., Kafatos F.C., Janeway C.A., Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science. 284:1999;1313-1318.
42. Garcia-Olmedo F., Molina A., Alamillo J.M., Rodriguez-Palenzuela P. Plant defense peptides. Biopolymers. 47:1998;479-491.
43. Lehrer R.I., Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 11:1999;23-27.
44. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers. 66:2002;236-248.
45. Lehrer R.I., Barton A., Daher K.A., Harwig S.S., Ganz T., Selsted M.E. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Invest. 84:1989;553-561.
46. Steiner H., Andreu D., Merrifield R.B. Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects. Biochim. Biophys. Acta. 939:1988;260-266.
47. Matsuzaki K., Harada M., Handa T., Funakoshi S., Fujii N., Yajima H.et al. Magainin 1-induced leakage of entrapped calcein out of negatively- charged lipid vesicles. Biochim. Biophys. Acta. 981:1989;130-134.
48. Pouny Y., Rapaport D., Mor A., Nicolas P., Shai Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry. 31:1992;12416-12423.
49. Gazit E., Lee W.J., Brey P.T., Shai Y. Mode of action of the antibacterial cecropin B2: a spectrofluorometric study. Biochemistry. 33:1994;10681-10692.
50. Matsuzaki K., Sugishita K., Miyajima K. Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of gram-negative bacteria. FEBS Lett. 449:1999;221-224.
51. Bechinger B. Biophysical investigations of membrane perturbations by polypeptides using solid-state NMR spectroscopy (review).[in process citation]. Mol. Membr. Biol. 17:2000;135-142.
52. Dathe M., Wieprecht T. Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta. 1462:1999;71-87.
53. Verkleij A.J., Zwaal R.F., Roelofsen B., Comfurius P., Kastelijn D., Deenen L.V. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta. 323:1973;178-193.
54. Zanetti M., Gennaro R., Skerlavaj B., Tomasinsig L., Circo R. Cathelicidin peptides as candidates for a novel class of antimicrobials. Curr. Pharm. Des. 8:2002;779-793.
55. Lehrer R.I., Ganz T. Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 9:2002;18-22.
56. Mangoni M.L., Rinaldi A.C., Di Giulio A., Mignogna G., Bozzi A., Barra D.et al. Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur. J. Biochem. 267:2000;1447-1454.
57. Agerberth B., Gunne H., Odeberg J., Kogner P., Boman H.G., Gudmundsson G.H. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. U.S.A. 92:1995;195-199.
58. Gudmundsson G.H., Agerberth B., Odeberg J., Bergman T., Olsson B., Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238:1996;325-332.
59. Oren Z., Lerman J.C., Gudmundsson G.H., Agerberth B., Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell selective activity. Biochem. J. 341:1999;501-513.
60. Lazarovici P., Primor N., Loew L.M. Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the red sea moses sole (Pardachirus marmoratus). J. Biol. Chem. 261:1986;16704-16713.
61. Thompson S.A., Tachibana K., Nakanishi K., Kubota I. Melittin-like peptides from the shark-repelling defense secretion of the sole Pardachirus pavoninus. Science. 233:1986;341-343.
62. Oren Z., Shai Y. A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Eur. J. Biochem. 237:1996;303-310.
63. Shai Y. Pardaxin: channel formation by a shark repellant peptide from fish. Toxicology. 87:1994;109-129.
64. Shai Y., Bach D., Yanovsky A. Channel formation properties of synthetic pardaxin and analogues. J. Biol. Chem. 265:1990;20202-20209.
65. Sal-Man N., Oren Z., Shai Y. Preassembly of membrane-active peptides is an important factor in their selectivity toward target cells. Biochemistry. 41:2002;11921-11930.
66. Ghosh J.K., Shaool D., Guillaud P., Ciceron L., Mazier D., Kustanovich I.et al. Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. J. Biol. Chem. 272:1997;31609-31616.
67. Feder R., Dagan A., Mor A. Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J. Biol. Chem. 275:2000;4230-4238.
68. Oren Z., Shai Y. Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry. 36:1996;1826-1835.
69. Blondelle S.E., Houghten R.A. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry. 31:1992;12688-12694.
70. Hong S.Y., Oh J.E., Lee K.H. Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochem. Pharmacol. 58:1999;1775-1780.
71. Fernandez-Lopez S., Kim H.S., Choi E.C., Delgado M., Granja J.R., Khasanov A.et al. Antibacterial agents based on the cyclic D,L-alpha-peptide architecture. Nature. 412:2001;452-455.
72. Maeda M., Melnyk R.A., Partridge A.W., Liu L.P., Deber C.M. Transmembrane segment peptides with double D-amino acid replacements: helicity, hydrophobicity, and antimicrobial activity. Biopolymers. 71:2003;77-84.
73. Epand R.F., Umezawa N., Porter E.A., Gellman S.H., Epand R.M. Interactions of the antimicrobial beta-peptide beta-17 with phospholipid vesicles differ from membrane interactions of magainins. Eur. J. Biochem. 270:2003;1240-1248.
74. Porter E.A., Wang X., Schmitt M.A., Gellman S.H. Synthesis and 12-helical secondary structure of beta-peptides containing (2R, 3R)-aminoproline. Org. Lett. 4:2002;3317-3319.
75. Oren Z., Hong J., Shai Y. A comparative study on the structure and function of a cytolytic alpha-helical peptide and its antimicrobial beta-sheet diastereomer. Eur. J. Biochem. 259:1999;360-369.
76. Oren Z., Shai Y. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Biochemistry. 39:2000;6103-6114.
77. Papo N., Shahar M., Eisenbach L., Shai Y. A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice. J. Biol. Chem. 278:2003;21018-21023.
78. Ehrenstein G., Lecar H. Electrically gated ionic channels in lipid bilayers. Q. Rev. Biophys. 10:1977;1-34.
79. Pouny Y., Shai Y. Interaction of D-amino acid incorporated analogues of pardaxin with membranes. Biochemistry. 31:1992;9482-9490.
80. Gazit E., Boman A., Boman H.G., Shai Y. Mechanism of interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry. 34:1995;11479-11488.
81. Gazit E., Boman A., Boman H.G., Shai Y. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry. 34:1995;11479-11488.
82. Ludtke S.J., He K., Heller W.T., Harroun T.A., Yang L., Huang H.W. Membrane pores induced by magainin. Biochemistry. 35:1996;13723-13728.
83. Matsuzaki K., Murase O., Miyajima K. Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. Biochemistry. 34:1995;12553-12559.
84. Hancock R.E., Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206:2002;143-149.
85. Mozsolits H., Wirth H.J., Werkmeister J., Aguilar M.I. Analysis of antimicrobial peptide interactions with hybrid bilayer membrane systems using surface plasmon resonance. Biochim. Biophys. Acta. 1512:2001;64-76.
86. Mozsolits H., Aguilar M.I. Surface plasmon resonance spectroscopy: an emerging tool for the study of peptide-membrane interactions. Biopolymers. 66:2002;3-18.
87. Papo N., Shai Y. New tumor cell selective lytic peptides based on the D,L-amphipathic helix motif. Biochemistry. 42:2003;9346-9354.
88. Unger T., Oren Z., Shai Y. The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implication to their mode of action. Biochemistry. 40:2001;6388-6397.
89. Avrahami D., Oren Z., Shai Y. Effect of multiple aliphatic amino acids substitutions on the structure, function, and mode of action of diastereomeric membrane active peptides. Biochemistry. 40:2001;12591-12603.
90. Allende D., McIntosh T.J. Lipopolysaccharides in bacterial membranes act like cholesterol in eukaryotic plasma membranes in providing protection against melittin-induced bilayer lysis. Biochemistry. 42:2003;1101-1108.
91. Rana F.R., Blazyk J. Interactions between the antimicrobial peptide, magainin 2, and Salmonella typhimurium lipopolysaccharides. FEBS Lett. 293:1991;11-15.
92. Zhang L., Scott M.G., Yan H., Mayer L.D., Hancock R.E. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry. 39:2000;14504-14514.
93. Frick I.M., Akesson P., Rasmussen M., Schmidtchen A., Bjorck L. SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J. Biol. Chem. 278:2003;16561-16566.
94. Tegos G., Stermitz F.R., Lomovskaya O., Lewis K. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents. Chemother. 46:2002;3133-3141.
95. Breukink E., Wiedemann I., van Kraaij C., Kuipers O.P., Sahl H., de Kruijff B. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science. 286:1999;2361-2364.
96. Fleury Y., Dayem M.A., Montagne J.J., Chaboisseau E., Le Caer J.P., Nicolas P.et al. Covalent structure, synthesis, and structure-function studies of mesentericin Y 105(37), a defensive peptide from gram-positive bacteria Leuconostoc mesenteroides. J. Biol. Chem. 271:1996;14421-14429.
97. Tachi T., Epand R.F., Epand R.M., Matsuzaki K. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity. Biochemistry. 41:2002;10723-10731.
98. Epand R.F., Lehrer R.I., Waring A., Wang W., Maget-Dana R., Lelievre D. et al. Direct comparison of membrane interactions of model peptides composed of only Leu and Lys residues. Biopolymers. 71:2003;2-16.
99. Oren Z., Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers. 47:1998;451-463.
100. Ladokhin A.S., White S.H. 'Detergent-like' permeabilization of anionic lipid vesicles by melittin. Biochim. Biophys. Acta. 1514:2001;253-260.